{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:03:26Z","timestamp":1782180206694,"version":"3.54.5"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1949,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1111\/j.1423-0410.2009.01304.x","type":"journal-article","created":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T04:03:12Z","timestamp":1263268992000},"page":"504-507","source":"Crossref","is-referenced-by-count":14,"title":["Fatal outcome of a hepatitis B virus transfusion-transmitted infection"],"prefix":"10.1111","volume":"98","author":[{"given":"C.","family":"Niederhauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Weingand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Candotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tinguely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. A.","family":"Wuillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Allain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB1","first-page":"134","article-title":"Blood donor screening: how to decrease the risk of transfusion transmitted Hepatitis B Virus?","volume":"138","author":"Niederhauser","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0042-9007.2004.00406.x","article-title":"Occult hepatitis B virus infection: implications in transfusion","volume":"86","author":"Allain","year":"2004","journal-title":"Vox Sang"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-3148.2002.00383.x","article-title":"The German experience with NAT","volume":"12","author":"Roth","year":"2002","journal-title":"Transfus Med"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1423-0410.2003.00289.x","article-title":"Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening","volume":"84","author":"Minegishi","year":"2003","journal-title":"Vox Sang"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB5","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/hep.21413","article-title":"Characterization of HBV DNA+\/HBsAg\u2212 blood donors in Poland identified by triplex NAT","volume":"44","author":"Brojer","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1537-2995.2008.01813.x","article-title":"Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey","volume":"48","author":"Velati","year":"2008","journal-title":"Transfusion"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1099\/vir.0.83347-0","article-title":"Molecular characterization of occult hepatitis B virus in genotype E-infected subjects","volume":"89","author":"Zahn","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB8","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/jmv.20963","article-title":"HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity","volume":"79","author":"Gerlich","year":"2007","journal-title":"J Med Virol"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1537-2995.2007.01276.x","article-title":"Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program","volume":"47","author":"Satake","year":"2007","journal-title":"Transfusion"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1537-2995.2007.01522.x","article-title":"Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C","volume":"48","author":"Komiya","year":"2008","journal-title":"Transfusion"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB11","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jmv.21320","article-title":"Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes","volume":"80","author":"Tabuchi","year":"2008","journal-title":"J Med Virol"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB12","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1537-2995.2006.00974.x","article-title":"Quantification of hepatitis B virus genomes and infectivity in human serum samples","volume":"46","author":"Hsia","year":"2006","journal-title":"Transfusion"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB13","volume-title":"Immunodeficiency and Recipients of Blood Transfusion","author":"Llewelyn","year":"2004"},{"key":"10.1111\/j.1423-0410.2009.01304.x-BIB14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2008.02.016","article-title":"Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients","volume":"48","author":"Levicnik-Stezinar","year":"2008","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1111\/j.1423-0410.2009.01304.x-BIB15","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1386-6532(06)80004-1","article-title":"Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation","volume":"36","author":"Gerlich","year":"2006","journal-title":"J Clin Virol"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.2009.01304.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1423-0410.2009.01304.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T17:24:25Z","timestamp":1711128265000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.2009.01304.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.2009.01304.x","relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}